B67.39
Echinococcus granulosus infection, other sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Echinococcus granulosus infection, classified under ICD-10 code B67.39, is a parasitic disease caused by the tapeworm Echinococcus granulosus. This infection primarily involves the formation of cysts in various tissues and organs, predominantly in the liver and lungs, but it can also affect other parts of the body. The condition is a significant health concern in regions where livestock raising is common, and it can cause a range of health complications if left untreated. Recognizing its symptoms, understanding its causes, and knowing the available treatment options are crucial for effective management of this condition.
Causes & Symptoms
Clinical Causes: Ingestion of food or water contaminated with tapeworm eggs shed in the feces of infected definitive hosts, commonly dogs, and other canids. Close contact with infected animals, especially in agricultural or rural settings where livestock and dogs coexist. Handling or consuming undercooked meat from infected intermediate hosts, such as sheep or cattle. Poor hygiene practices that facilitate the spread of eggs from animal feces to humans.
Key Symptoms: Often asymptomatic in the early stages. Development of cysts may cause localized symptoms based on their size and location, including: - Abdominal pain or discomfort, especially if cysts develop in the liver. - Shortness of breath or chest pain if cysts form in the lungs. - Nausea, vomiting, or jaundice in cases involving the biliary system. - General malaise, fatigue, or fever if secondary infections occur. Possible allergic reactions if cysts rupture, leading to anaphylaxis in rare cases.
Diagnostic & Treatment
Diagnosis Path: Diagnosing Echinococcus granulosus infection involves a combination of clinical assessment and diagnostic testing. Key methods include: - Imaging Tests: Ultrasound, CT scan, or MRI to visualize cysts' size, number, and location. - Serological Tests: Blood tests that detect specific antibodies or antigens related to the parasite. - Histopathological Examination: Biopsy of cyst tissue in certain cases to confirm diagnosis. - Differential Diagnosis: Ruling out other cystic or tumorous conditions with similar presentations. Early diagnosis is essential for effective treatment and better outcomes, especially in cases involving internal organs.
Treatment Protocols: Management of Echinococcus granulosus infection typically involves a combination of approaches, depending on cyst size, number, location, and the patient's overall health: - Surgical Intervention: Removal of cysts is often the preferred treatment, especially for accessible and sizable cysts. Techniques include cystectomy or pericystectomy. - Antiparasitic Medication: Use of drugs such as albendazole or mebendazole to reduce cyst size and prevent recurrence. - Percutaneous Techniques: Minimally invasive procedures like puncture, aspiration, injection, and re-aspiration (PAIR) are options for certain cyst types. - Supportive Care: Includes managing symptoms and monitoring for complications. - Prevention Strategies: Education on hygiene, proper cooking of meat, and controlling infection sources in animals. Treatment plans are tailored individually by healthcare providers to ensure safety and effectiveness.
Clinical Advice & FAQs
Billing Guidance
Is B67.39 a billable ICD-10 code?
Yes, B67.39 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B67.39?
Clinical documentation must specify the nature of Echinococcus granulosus infection, other sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
